Neurology ReviewsDepression linked to neuro dysfunction, brain lesions in MSMay 13, 2020Multiple Sclerosis
Neurology ReviewsInitial high-efficacy MS therapy tied to less disability laterMay 5, 2020Multiple Sclerosis
Neurology ReviewsCautionary findings on acquired immunodeficiency from anti-CD20 MS therapyMay 1, 2020Multiple Sclerosis
Neurology ReviewsReport details first case of PML with ocrelizumab aloneApril 30, 2020Multiple Sclerosis
Neurology ReviewsDatabase will collect data on COVID-19 in patients with MSApril 16, 2020COVID-19 UpdatesMultiple Sclerosis
Neurology ReviewsFDA removes pregnancy category C warning from certain MS medicationsApril 2, 2020Multiple Sclerosis
Neurology ReviewsFDA approves ozanimod for relapsing and secondary progressive forms of MSMarch 26, 2020Multiple Sclerosis
Clinical Neurology NewsClinicians petition government for national quarantineMarch 18, 2020COVID-19 UpdatesBusiness of MedicineMixed TopicsMultiple Sclerosis
Clinical Neurology NewsExpert says progress in gut-brain research requires an open mindMarch 13, 2020Parkinson's DiseaseAlzheimer's & CognitionMultiple SclerosisEpilepsy & SeizuresHeadache & MigraineMovement DisordersNeuromuscular Disorders
Neurology ReviewsTeriflunomide increases the likelihood of achieving NEDA in relapsing-remitting MSMarch 12, 2020Multiple Sclerosis
Clinical Neurology NewsManual dexterity may decline more rapidly in pediatric-onset MSMarch 11, 2020Multiple SclerosisPediatrics
